Select Publications
Journal articles
2012, 'P331 Role of infliximab as rescue therapy in hospitalised patients with severe, steroid refractory ulcerative colitis. Local experience. Liverpool and Bankstown hospitals, South Western Sydney Local Health District. Australia', Journal of Crohn's and Colitis, 6, pp. S141 - S142, http://dx.doi.org/10.1016/s1873-9946(12)60351-1
,2011, 'How to treat', Australian Doctor, pp. 27 - 34
,2010, 'Knowledge, perception and practices of colorectal cancer screening in an ethnically diverse population', Cancer Epidemiology, 34, pp. 604 - 610, http://dx.doi.org/10.1016/j.canep.2010.05.013
,2009, 'Colorectal cancer screening practice is influenced by ethnicity of patient and general practitioner', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A224 - A224, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Clinical and pathologic outcomes of colorectal cancer in a multi-ethnic population', Clinical Gastroenterology and Hepatology, 6, pp. 1016 - 1021
,2008, 'Improved survival in young women with colorectal cancer', American Journal of Gastroenterology, 103, pp. 1488 - 1495, http://dx.doi.org/10.1111/j.1572-0241.2007.01779.x
,2006, 'Managing inflammatory bowel disease', Medicine Today, 7, pp. 14 - 23
,2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, 139, pp. 411 - 420
,2004, 'CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease (vol 53, pg 1287, 2004)', GUT, 53, pp. 1722 - 1722, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224407200042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2004, 'CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, 53, pp. 1287 - 1294
,2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, 171, pp. 4990 - 4994, http://dx.doi.org/10.4049/jimmunol.171.10.4990
,2001, 'Heparin as an anti-inflammatory agent: It's no GAG to forget about chemokines [3]', Gut, 48, pp. 738, http://dx.doi.org/10.1136/gut.48.5.738
,2001, 'AMELIORATION OF MURINE TNBS COLITIS USING PREBIOTICS', Journal of Gastroenterology and Hepatology, 16, pp. 6 - 6, http://dx.doi.org/10.1111/j.1440-1746.2001.ca01-6.x
,2001, 'Amelioration of TNBS colitis in mice using preblotics', Gastroenterology, 120, pp. A82 - A82, http://dx.doi.org/10.1016/s0016-5085(08)80404-0
,1999, 'The effect of dosing with omeprazole on the accuracy of the 13C-urea breath test in Helicobacter pylori-infected subjects', Alimentary Pharmacology and Therapeutics, 13, pp. 1287 - 1293, http://dx.doi.org/10.1046/j.1365-2036.1999.00601.x
,1999, 'The impact of short-term ranitidine use on the precision of the 13C-urea breath test in subjects infected with Helicobacter pylori', European Journal of Gastroenterology and Hepatology, 11, pp. 1135 - 1138, http://dx.doi.org/10.1097/00042737-199910000-00010
,1998, 'Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma.', Am J Surg Pathol, 22, pp. 170 - 179, http://dx.doi.org/10.1097/00000478-199802000-00004
,1997, 'A case of upper gastrointestinal bleeding secondary to a bread bag clip', Australian and New Zealand Journal of Medicine, 27, pp. 75, http://dx.doi.org/10.1111/j.1445-5994.1997.tb00918.x
,1992, 'In vitro hydrogen production by enteric bacteria cultured from children with small bowel bacterial overgrowth', Journal of Pediatric Gastroenterology and Nutrition, 14, pp. 192 - 197, http://dx.doi.org/10.1097/00005176-199202000-00013
,1992, 'In Vitro Hydrogen Production by Enteric Bacteria Cultured from Children with Small Bowel Bacterial Overgrowth', Journal of Pediatric Gastroenterology and Nutrition, 14, pp. 192 - 197, http://dx.doi.org/10.1002/j.1536-4801.1992.tb10524.x
,Conference Papers
2023, 'IDDF2023-ABS-0141 The evolving role of technology in delivering patient-centric care in inflammatory bowel disease – an australasian experience using crohn’s colitis care e-health patient portal', in Clinical Gastroenterology, BMJ Publishing Group Ltd and British Society of Gastroenterology, pp. A203.1 - A203, presented at Abstracts of the International Digestive Disease Forum (IDDF), Hong Kong, 10–11 June 2023, http://dx.doi.org/10.1136/gutjnl-2023-iddf.193
,2023, 'IDDF2023-ABS-0146 Disease and treatment factors influencing outcomes in fistulising crohn’s disease', in Clinical Gastroenterology, BMJ Publishing Group Ltd and British Society of Gastroenterology, pp. A203.2 - A204, presented at Abstracts of the International Digestive Disease Forum (IDDF), Hong Kong, 10–11 June 2023, http://dx.doi.org/10.1136/gutjnl-2023-iddf.194
,2021, 'IDDF2021-ABS-0062 A novel decision aid improves knowledge and quality of pregnancy-related decision-making in IBD', in Clinical Gastroenterology, BMJ Publishing Group Ltd and British Society of Gastroenterology, pp. A108.1 - A108, presented at Abstracts of the International Digestive Disease Forum (IDDF), Hong Kong, 4–5 September 2021, http://dx.doi.org/10.1136/gutjnl-2021-iddf.126
,2019, 'Use of a novel tool to identify nutritional risk in an inflammatory bowel disease outpatient service: Liverpool IBD-Nutrition Screen', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 200 - 200, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'DELAY IN DIAGNOSIS OF ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', in INFLAMMATORY BOWEL DISEASES, OXFORD UNIV PRESS INC, NV, Las Vegas, pp. S4 - S4, presented at Crohn's and Colitis Congress, NV, Las Vegas, 07 February 2019 - 09 February 2019, http://dx.doi.org/10.1093/ibd/izy393.008
,2019, 'PATIENT AND HEALTHCARE PROFESSIONAL VIEWS ON EMOTIONAL HEALTH AND INTIMACY IN ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', in INFLAMMATORY BOWEL DISEASES, OXFORD UNIV PRESS INC, NV, Las Vegas, pp. S12 - S12, presented at Crohn's and Colitis Congress, NV, Las Vegas, 07 February 2019 - 09 February 2019, http://dx.doi.org/10.1093/ibd/izy393.027
,2018, 'Genetically distinct signatures of mild and severe ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 103 - 104, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Is there a difference in adalimumab drug levels according to pen versus syringe use: An international, multicenter retrospective analysis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 102 - 102, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'YUlcerative Colitis (UC) Narrative Study Australian data: A survey to compare patient and physician perspectives on communication and management of UC', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 105 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'CROHN'S COLITIS CARE (CCCARE) - DEVELOPMENT AND TESTING OF A BESPOKE CLOUD-BASED CLINICAL MANAGEMENT SYSTEM FOR INFLAMMATORY BOWEL DISEASE (IBD)', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S892 - S892, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011103425&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'GENETICALLY DISTINCT SIGNATURES OF MILD AND SEVERE ULCERATIVE COLITIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1025 - S1025, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011104106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'IN FECAL MICROBIOTA TRANSPLANTATION (FMT) FOR ULCERATIVE COLITIS, FUSOBACTERIUM IS ASSOCIATED WITH LACK OF REMISSION, WHILE METABOLIC SHIFTS TO STARCH DEGRADATION AND SHORT CHAIN FATTY ACID PRODUCTION ARE ASSOCIATED WITH REMISSION - RESULTS FROM THE RANDOMIZED CONTROLLED FOCUS STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S35 - S35, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011100099&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'VEDOLIZUMAB(VDZ) REAL WORLD OUTCOMES IN ULCERATIVE COLITIS (UC)', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S836 - S836, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011103257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Assessment of anti-tumor necrosis factor drug levels in people with Crohn's disease changes management decisions more often when done for loss of response than during remission', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 152 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Biological level testing in inflammatory bowel disease identifies inappropriate use of infliximab, with substantial associated cost savings', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 132 - 133, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100240&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Clinical predictors of severe ulcerative colitis requiring colectomy in Australia', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 145 - 145, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Crohn's Colitis Care (CCCare): A bespoke cloud-based clinical management system for inflammatory bowel disease - development and beta testing', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 131 - 131, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100237&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Drug-induced systemic lupus erythematosus in patients with inflammatory bowel disease treated with anti-tumor necrosis factor inhibitors: A case series', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 150 - 150, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100268&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Secondary loss of response is the most common indication for infliximab level testing in inflammatory bowel disease: The Australian experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 153 - 154, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Therapeutic drug monitoring-guided biological drug therapy in inflammatory bowel disease: Consensus statements of the Australian Inflammatory Bowel Disease Association (AIBDA) and Gastroenterological Society of Australia (GESA)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 136 - 138, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100247&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Treatment of ulcerative colitis with infliximab: Real-world outcomes are better than pivotal trials and improved with dose intensification', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 139 - 139, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100249&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Vedolizumab: Real-life outcomes to therapy in Crohn's disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 143 - 143, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100256&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Vedolizumab: Real-life outcomes to therapy in ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 142 - 142, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S4 - S5, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398606900008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Proving cost effectiveness through implementation of a nurse-led inflammatory bowel disease patient advice line and virtual clinic (CHEAP)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 174 - 174, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Effect on the intestinal microbiota and clinical outcome of faecal microbiota transplantation in patients with UC', in HELICOBACTER, WILEY-BLACKWELL, GERMANY, Magdeburg, pp. 72 - 72, presented at 29th International Workshop on Helicobacter and Microbiota in Inflammation and Cancer, GERMANY, Magdeburg, 15 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383517600017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, pp. S122 - S123, presented at Digestive Disease Week (DDW), CA, San Diego, 20 May 2016 - 24 May 2016, http://dx.doi.org/10.1016/S0016-5085(16)30517-0
,2016, 'Proving cost effectiveness through implementation of a nurse-led inflammatory bowel disease patient advice line and virtual clinic (CHEAP)', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S494 - S494, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374496600879&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'A single-blinded, randomised clinical trial: comparison between 2 different bowel preparation formulations split PrepKitC, a combined polyethylene glycol and sodium picosulfate-based solution and split prep Moviprep, a polyethylene glycol-based solution in the setting of outpatient colonoscopy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 45 - 45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364505900088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Bone health in inflammatory bowel disease patients - management by australian gastroenterologists is variable and poorly consistent with current guidelines', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 131 - 131, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364505900255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,